These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 8394563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A, Urban MO, Sluka KA.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [Abstract] [Full Text] [Related]

  • 5. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
    Spanagel R, Almeida OF, Shippenberg TS.
    Eur J Pharmacol; 1994 Oct 24; 264(2):157-62. PubMed ID: 7851478
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
    Catheline G, Kayser V, Guilbaud G.
    Eur J Pharmacol; 1996 Nov 14; 315(2):135-43. PubMed ID: 8960876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats.
    Vivian JA, Miczek KA.
    Psychopharmacology (Berl); 1998 Oct 14; 139(4):364-75. PubMed ID: 9809857
    [Abstract] [Full Text] [Related]

  • 11. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
    Catheline G, Guilbaud G, Kayser V.
    Eur J Pharmacol; 1998 Sep 18; 357(2-3):171-8. PubMed ID: 9797033
    [Abstract] [Full Text] [Related]

  • 12. Activation of micro, delta or kappa opioid receptors by DAMGO, DPDPE, U-50488 or U-69593 respectively causes antinociception in the formalin test in the naked mole-rat (Heterocephalus glaber).
    Towett PK, Kanui TI, Maloiy GM, Juma F, Olongida Ole Miaron J.
    Pharmacol Biochem Behav; 2009 Feb 18; 91(4):566-72. PubMed ID: 18929596
    [Abstract] [Full Text] [Related]

  • 13. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 18; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 14. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C, Levine JD.
    Brain Res; 1992 Nov 06; 595(1):32-8. PubMed ID: 1334770
    [Abstract] [Full Text] [Related]

  • 15. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ, Pettit HO, O'Neill SJ, Wei K, McNutt R, Bishop MJ, Chang KJ.
    J Pharmacol Exp Ther; 2003 Dec 06; 307(3):1221-6. PubMed ID: 14534368
    [Abstract] [Full Text] [Related]

  • 16. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Dec 06; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.